CoapTech, LLC
Baltimore, MD · Founded 2016 · CIK 0001823195 · Medtech · Private
PUMA-G system using magnetic coaptation and ultrasound for bedside gastrostomy placement
coaptech.com →- Grants
- $4.0M
- 7 awards
- Sector median: 1
- Raised
- $19M
- 4 Form D · Sep 2024
- 25 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 7
- 0 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Percutaneous Ultrasound Gastrostomy Development of a safer more affordable and more efficient method for feeding tube placement | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Percutaneous Ultrasound Gastrostomy: Clinical Evaluation of a Novel Method for Feeding Tube Placement | $1,234,262 | |
| Federal grant | Department of Health and Human Services · Phase I · Percutaneous Ultrasound Gastrostomy (PUG): Engineering and Feasibility Assessment of a Pediatric Device | $224,614 | |
| Federal grant | Department of Health and Human Services · Phase I · Percutaneous Ultrasound Gastrostomy (PUG):Engineering and Feasibility Assessment of a Pediatric Device | $224,614 | |
| Federal grant | Department of Health and Human Services · Phase II · Percutaneous Ultrasound Gastrostomy: Clinical Evaluation of a Novel Method for Feeding Tube Placement | $590,458 | |
| Private capital raised | Form D · SEC | $7,050,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Percutaneous Ultrasound Gastrostomy: Clinical Evaluation of a Feeding Tube Placement Method in the Pediatric Population | $768,234 | |
| Federal grant | Department of Health and Human Services · Phase II · Percutaneous Ultrasound Gastrostomy: Clinical Evaluation of a Feeding Tube Placement Method in the Pediatric Population | $774,058 | |
| Private capital raised | Form D · SEC | $785,000 | |
| Private capital raised | Form D · SEC | $4,000,000 | |
| Private capital raised | Form D · SEC | $7,072,474 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1400 | TORUS BIOSYSTEMS INC | — | $29M |
| 1401 | REDOLYNT, LLC | — | — |
| 1402 | MedicaMetrix, Inc/DE | — | $3.2M |
| 1403 | CoapTech, LLC | — | $19M |
| 1404 | SiPhox Inc. | — | $15M |
| 1405 | CATHBUDDY, INC. | — | $4.9M |
| 1406 | RESONEA, INC. | — | $12M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Peter BoydDirector
- Howard CarolanDirector · Executive Officer
- Tim CollinsDirector
- Timothy CollinsDirector · Executive Officer
- Jeffrey KatzDirector
- William NilandDirector
- John OsborneDirector
- Daniel TeoDirector
- Steven TropelloDirector · Executive Officer
- William WalkerDirector
Patents
- Systems, Apparatus, And Methods For Performing A Percutaneous Tracheostomyapplication
- Systems, Apparatus, And Methods For Performing A Percutaneous Tracheostomyapplication
- Systems, Apparatus, And Methods For Performing A Percutaneous Tracheostomyapplication
- Systems, Apparatus, And Methods For Delivering A Medical Device Beyond A Bifurcation In A Body Lumenapplication
- Systems, Apparatus, And Methods For Performing A Percutaneous Tracheostomyapplication
- Systems, Apparatus, And Methods For Performing A Percutaneous Tracheostomyapplication
- Systems, Apparatus, And Methods For Placing A Gastrostomy Tubeapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.